Pharmaceuticals

Leukapheresis Market Insights On Growth Drivers, Trends, And Opportunities

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Leukapheresis Market In 2026 And 2030?

The leukapheresis market has seen substantial growth recently. It is projected to expand from $72.02 billion in 2025 to $77.7 billion in 2026, at a compound annual growth rate (CAGR) of 7.9%. Historically, this market expansion can be linked to the rise in hematologic disorders, the broadening of cancer research programs, increased adoption of apheresis in blood centers, progress in centrifugation technologies, and an uptick in clinical research funding.

The leukapheresis market is anticipated to experience substantial growth in the upcoming years, with projections indicating it will reach $104.27 billion by 2030, advancing at a compound annual growth rate (CAGR) of 7.6%. This expansion during the forecast period is primarily fueled by the proliferation of CAR-T and cell-based therapies, increased funding for immunology research, a rising demand for personalized medical treatments, the enlargement of biopharmaceutical manufacturing capabilities, and technological improvements in apheresis automation. Significant trends expected during this period include the heightened utilization of leukapheresis in cell and gene therapies, a greater requirement for immune cell collection within oncology, the broader adoption of automated apheresis systems, an expansion of leukapheresis applications in clinical research, and an increased focus on developing patient-safe disposable apheresis kits.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp

Which Primary Drivers Are Impacting The Leukapheresis Market Growth?

The escalating prevalence of autoimmune diseases is poised to fuel the expansion of the leukapheresis market moving forward. These conditions are characterized by the immune system mistakenly attacking the body’s own healthy tissues. A disruption in immune balance, caused by reduced early-life microbial exposure and modern environmental factors, is leading to a higher incidence of autoimmune disorders. Leukapheresis provides a therapeutic approach for autoimmune diseases by specifically eliminating harmful white blood cells that contribute to the immune system targeting the body’s own tissues. For example, by September 2025, according to GetValue.co, a US-based online digital platform, autoimmune diseases are projected to affect an estimated 3–10% of the global population, amounting to approximately 600–800 million people worldwide. This demonstrates why the surge in autoimmune diseases is indeed driving the growth of the leukapheresis market.

What Are The Key Segment Divisions In The Leukapheresis Market Segment Structure?

The leukapheresis market covered in this report is segmented –

1) By Apheresis Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis

2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables

3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications

4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers

Subsegments:

1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis

2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis

3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes

What Trends Are Transforming The Leukapheresis Market?

Key companies within the leukapheresis market are concentrating on innovations, specifically the creation of GMP-grade leukopaks, to elevate the quality and effectiveness of cell therapy production. These GMP-grade leukopaks are products obtained through leukapheresis and processed according to rigorous good manufacturing practice (GMP) standards, which guarantees the high viability and functional capacity of the cells gathered for therapeutic uses. An example of this is the introduction of LeukoCer by Sanguine Biosciences, a US-based biotechnology company, in November 2024. This GMP-grade leukopak was developed to optimize workflows and expedite the advancement of cell therapies. LeukoCert provides premium starting materials, supplied as fresh whole or half packs, all manufactured under strict GMP standards, thus enabling researchers to further their studies and introduce novel cell therapies to the market more rapidly.

Which Organizations Are Engaged In The Leukapheresis Market?

Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., Haemonetics Corporation, Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories

Get The Full Leukapheresis Market Report:

https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report

Where Is The Leukapheresis Market Most Concentrated Geographically?

North America was the largest region in the leukapheresis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Leukapheresis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report

Browse Through More Reports Similar to the Global Leukapheresis Market 2026, By The Business Research Company

Leqembi Market Report 2026

https://www.thebusinessresearchcompany.com/report/leqembi-global-market-report

Leukemia Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report

Chronic Myeloid Leukemia Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795